1 – 10 of 246
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
- Validation of prostate cancer risk variants rs10993994 and rs7098889 by CRISPR/Cas9 mediated genome editing
- 2020
- Intake of individual fatty acids and risk of prostate cancer in the European prospective investigation into cancer and nutrition
- A nutrient-wide association study for risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition and the Netherlands Cohort Study
-
Targeted alpha therapy in a systemic mouse model of prostate cancer - a feasibility study
Stuparu, Andreea D. ; Meyer, Catherine A.L. ; Evans-Axelsson, Susan L. LU
; Lückerath, Katharina
; Wei, Liu H.
; Kim, Woosuk
; Poddar, Soumya
; Mona, Christine E.
; Dahlbom, Magnus
and Girgis, Mark D.
, et al.
(2020)
In Theranostics
10(6).
p.2612-2620
Mark
- Recent advances of PET imaging in clinical radiation oncology
- Do negative intrusive thoughts at diagnosis predict impaired quality of life, depressed mood and waking up with anxiety 3, 12 and 24 months after radical prostatectomy?–a longitudinal study
- Cytokines and Janus kinase/signal transducer and activator of transcription signaling in prostate cancer : overview and therapeutic opportunities
- Personalised biopsy schedules based on risk of Gleason upgrading for patients with low-risk prostate cancer on active surveillance
- Risk of Recurrent Disease 6 Years After Open or Robotic-assisted Radical Prostatectomy in the Prospective Controlled Trial LAPPRO
- Genetic signature of prostate cancer mouse models resistant to optimized hK2 targeted α-particle therapy